Option Care Health’s (OPCH) “Outperform” Rating Reaffirmed at Barrington Research

Barrington Research reiterated their outperform rating on shares of Option Care Health (NASDAQ:OPCH) in a research report released on Wednesday, Benzinga reports. Barrington Research currently has a $40.00 price target on the stock.

Separately, JMP Securities raised their price target on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th.

Option Care Health Trading Down 1.0 %

NASDAQ OPCH opened at $29.45 on Wednesday. Option Care Health has a 12 month low of $26.11 and a 12 month high of $34.63. The company has a current ratio of 1.76, a quick ratio of 1.36 and a debt-to-equity ratio of 0.78. The stock’s fifty day moving average price is $31.00 and its 200-day moving average price is $30.08. The stock has a market cap of $5.12 billion, a P/E ratio of 19.38, a P/E/G ratio of 2.31 and a beta of 1.29.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.03. The company had revenue of $1.23 billion for the quarter, compared to analysts’ expectations of $1.17 billion. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. Option Care Health’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.63 EPS. As a group, equities analysts forecast that Option Care Health will post 1.22 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is owned by insiders.

Institutional Trading of Option Care Health

Several large investors have recently modified their holdings of OPCH. Diversify Wealth Management LLC boosted its position in Option Care Health by 15.3% in the third quarter. Diversify Wealth Management LLC now owns 10,299 shares of the company’s stock worth $309,000 after purchasing an additional 1,364 shares during the last quarter. Pinnacle Associates Ltd. lifted its stake in shares of Option Care Health by 11.6% in the 3rd quarter. Pinnacle Associates Ltd. now owns 30,066 shares of the company’s stock worth $1,013,000 after purchasing an additional 3,137 shares during the period. Nisa Investment Advisors LLC lifted its stake in shares of Option Care Health by 7.0% in the 3rd quarter. Nisa Investment Advisors LLC now owns 14,526 shares of the company’s stock worth $455,000 after purchasing an additional 945 shares during the period. State of Alaska Department of Revenue boosted its holdings in shares of Option Care Health by 3.8% in the third quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company’s stock worth $621,000 after buying an additional 735 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC bought a new stake in Option Care Health during the third quarter valued at approximately $206,000. Institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.